Chemours Co Earnings Per Share Disclosure
Note 10. Earnings Per Share of Common Stock
The following table sets forth the reconciliations of the numerators and denominators of the Company’s basic and diluted earnings (loss) per share calculations for the years ended December 31, 2025, 2024 and 2023.
|
|
Year Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Numerator: |
|
|
|
|
|
|
|
|
|
|||
Net (loss) income attributable to Chemours |
|
$ |
(386 |
) |
|
$ |
69 |
|
|
$ |
(253 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|||
Weighted-average number of common shares |
|
|
150,237,101 |
|
|
|
149,494,462 |
|
|
|
148,912,397 |
|
Dilutive effect of the Company’s employee |
|
|
— |
|
|
|
677,827 |
|
|
|
— |
|
Weighted-average number of common shares |
|
|
150,237,101 |
|
|
|
150,172,289 |
|
|
|
148,912,397 |
|
|
|
|
|
|
|
|
|
|
|
|||
Basic (loss) earnings per share of common stock (2) |
|
$ |
(2.57 |
) |
|
$ |
0.46 |
|
|
$ |
(1.70 |
) |
Diluted (loss) earnings per share of common stock (1) (2) |
|
|
(2.57 |
) |
|
|
0.46 |
|
|
|
(1.70 |
) |
The following table sets forth the average number of stock options and performance stock options that were out of the money and, therefore, were not included in the Company’s diluted earnings (loss) per share calculations for the years ended December 31, 2025, 2024 and 2023.
|
|
Year Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Average number of stock options |
|
|
4,353,418 |
|
|
|
2,246,602 |
|
|
|
1,444,099 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 24, 2026 | Showing above |
| 2024 | Feb 18, 2025 | |
| 2023 | Mar 27, 2024 | |
| 2022 | Feb 10, 2023 | |
| 2021 | Feb 11, 2022 | |
| 2020 | Feb 12, 2021 | |
| 2019 | Feb 14, 2020 | |
| 2018 | Feb 15, 2019 | |
| 2017 | Feb 16, 2018 | |
| 2016 | Feb 17, 2017 | |
| 2015 | Feb 25, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.